Risa International Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Risa International Ltd is ₹ 0.4 as of 23 Oct 15:30 . The P/E Ratio of Risa International Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Risa International Ltd changed from ₹ 6.86 crore on March 2021 to ₹ 7.02 crore on March 2026 . This represents a CAGR of 0.39% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Risa International Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Risa International Ltd for the Jun '26 is ₹ -0.12 crore as compare to the Mar '26 ebitda of ₹ -0.16 crore. This represent the decline of -25% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Risa International Ltd changed from ₹ -0.12 crore to ₹ -0.4 crore over 9 quarters. This represents a CAGR of 70.76% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Risa International Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Risa International Ltd

Risa International Limited was originally incorporated on March 09, 1993 as 'Govindji Trikamdas Exports Limited'.
Thereafter, the name of the Company was changed to Risa International Limited effective on 28th June, 2011.
The Company is engaged into the business of textiles and real estate. In FY 2015, the Company formed three wholly owned subsidiaries viz; Risa Universal Limited (Hong Kong), Risa Global Limited (UK), and RISA International F.Z.E.(UAE); of which two wholly owned subsidiaries i.e.
Risa Global Ltd. (UK), & Risa International F.Z.E (UAE) closed down in 2016-17. The Company is driven by passionate promoters from the industry engaged in textile, garments and collection & processing of iron and steel scraps for recycling with a view to strengthen its existing platforms and building new ones.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Risa International Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Risa International Ltd is 6 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Risa International Ltd stock price is INR ₹0.4. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Risa International Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.